InvestLog
LYRA Lyra Therapeutics, Inc. logo

LYRA Lyra Therapeutics, Inc.

Healthcare
$0.44-11.98%ClosedMarket Cap: $781,126

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

0

Dispositions

3

Buy/Sell Ratio

0.00

Net Shares

-3,307

Shares Acquired

0

Shares Disposed

3,307

Total Bought ($)

$0.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri May 15Smith W BradforddirectorSell640$0.000
Fri Apr 03Palasis Mariadirector, officer: Principal Executive OfficerSell2,000$0.001,094,733
Fri Apr 03Cavalier Jasonofficer: Principal Financial OfficerSell667$0.00517,880
Thu Jan 08Palasis Mariadirector, officer: President & CEOSell1,702$3.361,096,733
Thu Jan 08Cavalier Jasonofficer: Chief Financial OfficerSell769$3.36518,547
Thu Nov 13PERCEPTIVE ADVISORS LLC10 percent ownerSell28,597$3.90124,859
Thu Nov 13PERCEPTIVE ADVISORS LLC10 percent ownerSell7,862$4.06153,456
Thu Nov 13PERCEPTIVE ADVISORS LLC10 percent ownerSell4,783$4.31161,318
Thu Nov 13PERCEPTIVE ADVISORS LLC10 percent ownerSell3,213$3.9014,026
Thu Nov 13PERCEPTIVE ADVISORS LLC10 percent ownerSell883$4.0617,239
Thu Nov 13PERCEPTIVE ADVISORS LLC10 percent ownerSell537$4.3118,122
Mon Nov 10PERCEPTIVE ADVISORS LLC10 percent ownerSell28,902$5.18200,480
Mon Nov 10PERCEPTIVE ADVISORS LLC10 percent ownerSell17,746$4.75182,734